Lactoferrin as an adjuvant in cancer vaccines

Details for Australian Patent Application No. 2004289170 (hide)

Owner Agennix Incorporated

Inventors Pericle, Federica; Varadhachary, Atul

Agent Pizzeys

Pub. Number AU-B-2004289170

PCT Pub. Number WO2005/046571

Priority 60/498,236 27.08.03 US; 60/476,318 06.06.03 US

Filing date 7 June 2004

Wipo publication date 26 May 2005

Acceptance publication date 17 December 2009

International Classifications

A61K 38/40 (2006.01) Medicinal preparations containing peptides - Transferrins, e.g. lactoferrins, ovotransferrins

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

Event Publications

15 December 2005 PCT application entered the National Phase

  PCT publication WO2005/046571 Priority application(s): WO2005/046571

17 December 2009 Application Accepted

  Published as AU-B-2004289170

15 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004289172-Pro 104 antibody compositions and methods of use

2004289168-Electronic earplug for monitoring and reducing wideband noise at the tympanic membrane